Navigation Links
Adult stem cell application effective in treatment of peripheric vascular disease
Date:1/24/2008

Multipotent adult progenitor stem cells extracted from bone marrow, and known as MAPCs, have proved to be effective in the regeneration of blood vessel tissue and also in muscle tissue when treating peripheric vascular disease. This was the result of research undertaken with mouse models by two research groups, one by the University Hospital of Navarra jointly with the Centre for Applied Medical Research (CIMA), also of the University of Navarra, and the other by the Centre for Molecular and Vascular Biology atthe Catholic University of Leuven (Belgium).

The results of the study have been recently published as an article in The Journal of Clinical Investigation the main author of which is doctor in Biology at the University Hospital of the University of Navarra and CIMA, Xabier Lpez Aranguren. The study was part of a line of research for his PhD thesis. The directors of the current research are doctors Felipe Prsper, for the University Hospital of Navarra and CIMA and Aernout Luttun and Catherine M. Verfaille for the Catholic University of Leuven.

Aim of research

Acute peripheric vascular disease involves the obstruction of the blood circulation in a determined area of the organism, as a consequence of the occlusion of the artery supplying blood to it, with the consequent reduction in blood flow. If it is not treated in time, the ischemia can cause various complications; the worst scenario being tissue necrosis, gangrene, or even the loss of an affected limb. In any case, the basic effect of peripheric ischemia is an important loss of vascularisation in the affected area, as well as in the musculature.

The research work published in The Journal of Clinical Investigation analysed the role and potential of two different types of cell-based treatments for peripheric vascular disease. It was based on the use of experimental mice models that were treated for this blood vessel ailment using MAPC cells implant a
'/>"/>

Contact: Egoitz Etxebeste
egoitz@elhuyar.com
Elhuyar Fundazioa
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Air pollution linked to cardiovascular risk indices in healthy young adults
2. Urban Smog Tough on Young Adults Hearts
3. Heart Attacks at School Involve More Adults Than Kids
4. Governor Rendell Offers adultBasic Coverage to 35,000 Uninsured Pennsylvanians
5. Computer-Related Eye Strain Not Just for Adults
6. Adult offspring of parents with PTSD have lower cortisol levels
7. Rates of bipolar diagnosis in youth rapidly climbing, treatment patterns similar to adults
8. ADDAS Awareness Campaign Offers Resources and Education to Adults Living with AD/HD and Professionals Working With Them
9. Office-Based Medical Treatment and Internet Resources Are Potential Solution to Rising Painkiller Misuse Among Teens, Young Adults
10. Stem cells in adult testes provide alternative to embryonic stem cells for organ regeneration
11. Stem cells derived from adult testes produce wide range of tissue types

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...8 Pharmaceutical Resear...e President Ken Johnson released the following sta...: ,, "We are disappointed, but not surprised by...of hardworking Americans as well as nearly half of...who voted against the bill. ,, "While well inte...
(Date:11/8/2009)... Shows Who Sides With Working Families vs. Insuran...swire-USNewswire/ -- On the heels of an historic l... a good, balanced health care reform bill, the Pen...state,s U.S. representatives voted on HR 3962, the...e legislation, which passed Saturday evening by a ...
(Date:11/7/2009)...v. 7 Speaker Nancy Pel....R. 3962, the Affordable Health Care for America A...tonight. Below are the Speaker,s remarks. ,, ...ric moment for our nation and for American familie...nd political philosophy -- as far back as Teddy Ro...
(Date:11/7/2009)...PRNewswire/ -- Calling this a "defining moment" fo...President J. James Rohack, M.D., today addressed m...te and medical specialty societies at the opening ...ere health system reform will top the agenda. ,...81209/AMALOGO ) ,, "Over the next 72 hours, t...
(Date:11/7/2009)...7 The U.S. bishops Nove...es to vote for the Stupak-Ellsworth Amendment to t...-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment ... funding and conscience protections in the Afforda... said. ,, The letter was signed by Cardinal Jus...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2
...Alseres Pharmaceuticals, Inc. today announced that...ASDAQ Stock Market ("NASDAQ") that for the last 10... listed securities has been below the minimum $35 ...NASDAQ Marketplace Rule 4310(c)(3)(A) or 4310(c)(3...
...scular group practice to use Sage Intergy solution...ition itself for pay-for-performance , , TAMPA, F...scular Institute, a Saginaw-Mich.-based group prac...(PM) and Sage Intergy EHR electronic health reco...
...eveal targets for future treatments , , MO...they have discovered genes in prostate cancer cell...th each other, an occurrence that may initiate the...cer cells, a finding that may serve as a marker fo...
...an Inc. (Nasdaq: MYL ),today announced that its ...onal U.S. patents protecting the company,s Perforo... pulmonary disease (COPD) treatment. , U.S. Pa...ormoterol. This patent covers Dey,s Perforomist(R)...
...publication of its kind aimed at healthcare fraud ...e Insight(R) (HCI), a Verisk HealthCare company an... and overpayment prevention solutions for healthca...lication dedicated to helping public and private s...
... Boehringer Ingelheim today announced the appoint...Sales and Marketing for the company,s Prescription...ad the U.S. sales and marketing strategy of Boehri...ef Executive Officer, Boehringer Ingelheim Corpora...
Other Medicine News:Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 2Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 3Health News:Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements 4Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 2Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 3Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 4Health News:Michigan CardioVascular Institute Selects Sage Intergy EHR to Streamline Clinical, Workflow and Reporting Efficiencies 5Health News:U.S. Patent and Trademark Office Issues Mylan's Specialty Division, Dey L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution 2Health News:HealthCare Insight(R) Launches Industry Fraud Magazine 2Health News:Boehringer Ingelheim Appoints Albert Ros as Executive Vice President of Sales and Marketing for Prescription Medicines 2
(Date:11/6/2009)..., Nov. 6 Caraco Pharmace...aunched ketorolac tromethamine ophthalmic solution... and Drug Administration (FDA) for Sun Pharma,s Ab...Acular® opthalmic solution on the first day f...olac is therapeutically equivalent to Acular®...
(Date:11/6/2009)...IS, November 6 , - Trial ...lid for the,Treatment of Multi-Resistant Staphyloc... a speciality pharmaceutical company focused on th...esigned to overcome the significant global,problem... most advanced oral,antibacterial NXL103 (floprist...
(Date:11/5/2009)...GO, Nov. 5 Althea Technologies, I...turing services for biopharmaceutical products ann...lopment to the company,s platform of services, whi...es Matsuura, Director of Formulation Development. ...ion and analytical scientists, along with new labo...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 1Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 3Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 12721 4Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 1Geographic profiling applied to track hunting patterns of white sharks in South Africa 8945 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 1Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 2Iran Blocks Access to the Chopra Center 26apos 3Bs Web Site Podcasts and Blogs 49586 3
...Company Planning to Initiate Phase 2 Trials in Col...Cancer in Q307 -, SOUTH SAN FRANCISCO, Calif., Jun...aceuticals, Inc. , a,biopharmaceutical company foc...s from an interim safety analysis of two Phase 1,d...ion platinum for,the potential first-line treatmen...
...ven year follow up of pivotal trial confirms that ...EL, Switzerland, June 4, 2007-A follow-up analysis...non-Hodgkin,s lymphoma,(NHL) who were treated with...) over seven years ago has revealed exciting resul...ase III study has shown,that over half (53%) of th...
Other Medicine Technology:Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 2Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 3Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 4Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 5Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 6MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 2MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 3MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone 4
RNA1c Control for Bayer DCA 2000 and 2000 + Analyzers
Molteno3 Glaucoma Drainage Device
...s a reagent and probe system used together to quan...t plate based system is a sandwich nucleic acid hy...for RNA detection and quantification, by amplifyin...chnology. Branched DNA allows immediate quantifica...
Cormet Hip Resurfacing System
Medicine Products: